Surprising EXCEL Outcomes in Diabetics with Main Left Stenosis

This study especially designed to compare PCI vs. CABG in patients with left main coronary artery disease and low to intermediate Syntax score showed that 30-day and 3 -year outcomes of PCI with everolimus eluting stents vs CABG were consistent both in diabetic and non-diabetic patients.

angioplastia a tronco de coronaria izquierda vs cirugiaThe randomized EXCEL trial (Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) reports a similar combined events rate (death, myocardial infarction or stroke) at 3 years in patients with left main lesion and low to intermediate Syntax score treated with PCI or CABG. This global data (published in the New England Journal of Medicine (NEJM) in 2016 and commented on our website) could be different por diabetics, who are at higher risk and have historically seen better benefits from surgery, as showed by the vast number of prior studies.

 

This is why this EXCEL sub-study has come as a surprise, seeing as it was already pre-specified in the original protocol, which makes it more relevant than a post-hoc sub-study.


Read also: The Significance of Aetiology on Mitral Regurgitation.


The EXCEL included 1905 patients with left main coronary artery disease and low to intermediate Syntax (≤32) randomized 1:1 to PCI with everolimus eluting stent vs. CABG stratified by the presence of diabetes. Primary end point was a composite of all cause death, stroke and MI at 3 years. Outcomes were examined in 554 diabetic patients vs 1350 non-diabetic.

 

At 3 years, the combined end point was significantly higher in the diabetic population (20.0% vs. 12.9%; p<0.001). However, in the diabetic cohort, outcomes were similar with PCI and CABG (20.7% vs. 19.3%, respectively; HR: 1.03; CI 95% 0.71 to 1.50; p=0.87), and were also similar (almost identical) in the non-diabetic cohort (12.9% vs. 12.9%, respectively; HR: 0.98; CI 95%: 0.73 to 1.32; p=0.89).


Read also: Would TAVR Have a Similar Benefit in Patients with Low Flow, Low Gradient, and Preserved Ejection Fraction?


All-cause death occurred in 13.6% of patients receiving PCI vs. 9% in the CABG group (p=0.046). Regardless, diabetes had no significant interaction with any of the end point, be there primary (p=0.82) or secondary, such as death, MI or stroke at 30 days (p=0.61), or death, MI, stroke or ischemia driven revascularization at 3 years (p=0.65).

 

Conclusion

The EXCEL outcomes, both at 30 days and 3 years, were consistent both for the diabetic and the non-diabetic populations in patients receiving PCI or CABG to treat left main coronary artery disease with low to intermediate syntax score.

 

Original title: Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients with Diabetes.

Reference: Milan Milojevic et al. J Am Coll Cardiol 2019;73:1616–28.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...